Summary of Ensign Group Q2 2026 Earnings Call

1Key Financial Results and Metrics

GAAP Diluted EPS:: $1.68, up 16.7% year-over-year.

Adjusted Diluted EPS:: $1.92, up 20.8% year-over-year.

Consolidated GAAP Revenue:: $1.4 billion, an increase of 17.3%.

GAAP Net Income:: $99.7 million, up 18.2%.

Adjusted Net Income:: $114.3 million, up 22.5%.

Cash and Cash Equivalents:: $262.3 million.

Cash Flows from Operations:: $272.1 million.

Annual Earnings Guidance:: Increased to $7.75 - $7.85 per diluted share, from $7.48 - $7.62.

Annual Revenue Guidance:: Increased to $5.87 - $5.92 billion, from $5.81 - $5.86 billion.

2Strategic Updates and Business Highlights

Occupancy Rates:: Same-store occupancy at 84.1%, with transitioning occupancy at 84.7%. Managed care revenue increased by 6.1% for same-store operations.

Acquisitions:: 20 new operations added during the quarter, totaling 102 since 2024. Focus on high-quality facilities in Texas and Iowa.

Clinical Excellence:: Achieved quality measure ratings 23% above state averages, with zero CMS Special Focus facilities.

Employee Stability:: Improved turnover rates, with RN retention 8% better than the average across their footprint.

Standard Bearer Healthcare REIT:: Generated rental revenue of $44.1 million, with $37.8 million from Ensign-affiliated operations.

3Forward Guidance and Outlook

Growth Confidence:: Management expressed confidence in achieving the revised earnings and revenue guidance due to strong operational momentum and demographic tailwinds.

Long-term Growth:: Continued focus on acquiring operations with significant upside and improving existing facilities to reach mid-90% occupancy levels.

4Bad News, Challenges, or Points of Concern

Acquisition Integration:: Newly acquired facilities are expected to take time to generate expected returns, with many currently operating below average occupancy.

CMS Rating Changes:: Anticipated changes in CMS quality measure ratings could impact future ratings, although initial assessments suggest limited negative effects.

Competitive Pressures:: The healthcare environment remains competitive, with ongoing challenges in maintaining staffing levels and managing costs.

5Notable Q&A Insights

CMS Quality Measures:: Management is cautiously optimistic about the impact of CMS rating changes, with preliminary analyses indicating limited negative effects on their facilities.

Share Repurchase Program:: The company has a history of share repurchases, which they view as a strategic component of capital deployment alongside acquisitions and dividends.

Labor Dynamics:: Contract labor usage has stabilized at low levels, and turnover rates are improving faster than industry averages, which is encouraging for operational performance.

Southeast Market Performance:: The company is seeing positive results in the Southeast, with plans for further expansion in underpenetrated areas. This summary encapsulates the key takeaways from the earnings call, highlighting Ensign Group's financial performance, strategic initiatives, and outlook while addressing potential challenges and insights from the Q&A session.